Sanara MedTech Inc. Common Stock (SMTI) is a publicly traded Healthcare sector company. As of May 21, 2026, SMTI trades at $23.00 with a market cap of $200.60M and a P/E ratio of -5.28. SMTI moved +1.96% today. Year to date, SMTI is -2.38%; over the trailing twelve months it is -25.90%. Its 52-week range spans $16.05 to $39.08. Analyst consensus is buy with an average price target of $34.00. Rallies surfaces SMTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sanara MedTech Expands Distributors to 450+, Q1 Revenue Guidance Up 14-16%: Sanara MedTech’s full-year 2025 adjusted EBITDA surged 86% to $17 million and cash from operations jumped to $6.8 million from a $24,000 outflow, while Q4 net loss narrowed to $1.1 million from a $0.9 million gain a year earlier. The company expanded its distributor network to over 450 partners and forecasted Q1 2026 revenue of $26.7–$27.2 million, a 14–16% increase year-over-year.
| Metric | Value |
|---|---|
| Price | $23.00 |
| Market Cap | $200.60M |
| P/E Ratio | -5.28 |
| EPS | $-4.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.08 |
| 52-Week Low | $16.05 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $103.12M |
| Net Income | $-37.57M |
| Gross Margin | 92.71% |
2 analysts cover SMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $34.00.